Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Mar 29 2022

Cite this